EYE vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

58MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

EYE MVP
Technical
46
68
Catalyst
54
50
Sentiment
50
50
Fundamental
60
95
Momentum
65
51
Risk Gate
50
50

Key Metrics

EYE Metric MVP
$38.5MMarket Cap$52.9M
199KAvg Volume (20d)214K
N/AShort InterestN/A
$0.20552-Week High$0.765
$0.10052-Week Low$0.365
+3.8%Daily Change+2.2%
$0.135Reference Price$0.460
-26.1%ROE+1.1%
-12.4%Profit Margin+1.5%

Active Signals

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare EYE and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs CUV →CGS vs MVP →EYE vs IMM →AHC vs EYE →AHC vs ATH →
EYE Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).